Remimazolam TIVA
PreclinicalSmall molecule
Remimazolam TIVA is one of 5 small molecule programs targeting Quality of Recovery. It is currently in Preclinical.
2
Indications
3
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
4 competitors in Laryngeal Mask Airway
#DrugCompanyPhaseTrials
1Alfenta
Jazz PharmaceuticalsPreclinical
Nimbex
AbbViePreclinical
Remimazolam TIVA
YYonsei University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
General Anesthesia1 trial
Quality of Recovery1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Remimazolam TIVA. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- YYonsei University